Genetic variants of FZD4 and LRP5 genes in patients with advanced retinopathy of prematurity

Molecular Vision

Volumn 19, Issue , 2013, Pages 476-485

  Kondo, Hiroyuki ^a   Kusaka, Shunji ^b,c   Yoshinaga, Aki ^d   Uchio, Eiichi ^e   Tawara, Akihiko ^a   Tahira, Tomoko ^d  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

^e FUKUOKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; COMPLEMENTARY DNA; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5;

AMINO ACID SUBSTITUTION; ARTICLE; CODON; CONTROLLED STUDY; EXON; FAMILIAL EXUDATIVE VITREORETINOPATHY; FEMALE; FZD4 GENE; GENE; GENE FREQUENCY; GENETIC VARIABILITY; HUMAN; INFANT; JAPANESE; LASER COAGULATION; LENSECTOMY; LRP5 GENE; MAJOR CLINICAL STUDY; MALE; NDP GENE; NONHUMAN; NONSYNONYMOUS SINGLE NUCLEOTIDE POLYMORPHISM; NUCLEIC ACID BASE SUBSTITUTION; PATHOGENICITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROLENTAL FIBROPLASIA; SCLERA BUCKLING PROCEDURE; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TSPAN12 GENE; VITRECTOMY; VITREORETINOPATHY;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; FRIZZLED RECEPTORS; GENETIC VARIATION; HUMANS; INFANT; INFANT, NEWBORN; JAPAN; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-5; MALE; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; RETINOPATHY OF PREMATURITY; SEQUENCE HOMOLOGY, AMINO ACID; TETRASPANINS;

EID: 84874402513     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Shastry BS. Genetic susceptibility to advanced retinopathy of prematurity (ROP). J Biomed Sci 2010; 17:69 [PMID: 20738858.
2. Holmström G, van Wijngaarden P, Coster DJ, Williams KA. Genetic susceptibility to retinopathy of prematurity: the evidence from clinical and experimental animal studies. Br J Ophthalmol 2007; 91:1704-8. [PMID: 18024814.
3. Bizzarro MJ, Hussain N, Jonsson B, Feng R, Ment LR, Gruen JR, Zhang H, Bhandari V. Genetic susceptibility to retinopathy of prematurity. Pediatrics 2006; 118:1858-63. [PMID: 17079555.
4. Chen ZY, Battinelli EM, Fielder A, Bundey S, Sims K, Breakefield XO, Craig IW. A mutation in the Norrie disease gene (NDP) associated with X-linked familial exudative vitreoretinopathy. Nat Genet 1993; 5:180-3. [PMID: 8252044.
5. Robitaille J, MacDonald ML, Kaykas A, Sheldahl LC, Zeisler J, Dube MP, Zhang LH, Singaraja RR, Guernsey DL, Zheng B, Siebert LF, Hoskin-Mott A, Trese MT, Pimstone SN, Shastry BS, Moon RT, Hayden MR, Goldberg YP, Samuels ME. Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy. Nat Genet 2002; 32:326-30. [PMID: 12172548.
6. Toomes C, Bottomley HM, Jackson RM, Towns KV, Scott S, Mackey DA, Craig JE, Jiang L, Yang Z, Trembath R, Woodruff G, Gregory-Evans CY, Gregory-Evans K, Parker MJ, Black GC, Downey LM, Zhang K, Inglehearn CF. Mutations in LRP5 or FZD4 underlie the common familial exudative vitreoretinopathy locus on chromosome 11q. Am J Hum Genet 2004; 74:721-30. [PMID: 15024691.
7. Poulter JA, Ali M, Gilmour DF, Rice A, Kondo H, Hayashi K, Mackey DA, Kearns LS, Ruddle JB, Craig JE, Pierce EA, Downey LM, Mohamed MD, Markham AF, Inglehearn CF, Toomes C. Mutations in TSPAN12 cause autosomal-dominant familial exudative vitreoretinopathy. Am J Hum Genet 2010; 86:248-53. [PMID: 20159112.
8. Nikopoulos K, Gilissen C, Hoischen A, van Nouhuys CE, Boonstra FN, Blokland EA, Arts P, Wieskamp N, Strom TM, Ayuso C, Tilanus MA, Bouwhuis S, Mukhopadhyay A, Scheffer H, Hoefsloot LH, Veltman JA, Cremers FP, Collin RW. Next-generation sequencing of a 40 Mb linkage interval reveals TSPAN12 mutations in patients with familial exudative vitreoretinopathy. Am J Hum Genet 2010; 86:240-7. [PMID: 20159111.
9. Shastry BS, Pendergast SD, Hartzer MK, Liu X, Trese MT. Identification of missense mutations in the Norrie disease gene associated with advanced retinopathy of prematurity. Arch Ophthalmol 1997; 115:651-5. [PMID: 9152134.
10. Hiraoka M, Berinstein DM, Trese MT, Shastry BS. Insertion and deletion mutations in the dinucleotide repeat region of the Norrie disease gene in patients with advanced retinopathy of prematurity. J Hum Genet 2001; 46:178-81. [PMID: 11322656].
11. Talks SJ, Ebenezer N, Hykin P, Adams G, Yang F, Schulenberg E, Gregory-Evans K, Gregory-Evans CY. De novo mutations in the 5′ regulatory region of the Norrie disease gene in retinopathy of prematurity. J Med Genet 2001; 8:E46 [PMID: 11748312.
12. Haider MZ, Devarajan LV, Al-Essa M, Kumar HA. C597→A polymorphism in the Norrie disease gene is associated with advanced retinopathy of prematurity in premature Kuwaiti infants. J Biomed Sci 2002; 9:365-70. [PMID: 12145535.
13. Hutcheson KA, Paluru PC, Bernstein SL, Koh J, Rappaport EF, Leach RA, Young TL. Norrie disease gene sequence variants in an ethnically diverse population with retinopathy of prematurity. Mol Vis 2005; 11:501-8. [PMID: 16052165.
14. Hiraoka M, Takahashi H, Orimo H, Hiraoka M, Ogata T, Azuma N. Genetic screening of Wnt signaling factors in advanced retinopathy of prematurity. Mol Vis 2010; 16:2572-7. [PMID: 21151595.
15. Ells A, Guernsey DL, Wallace K, Zheng B, Vincer M, Allen A, Ingram A, DaSilva O, Siebert L, Sheidow T, Beis J, Robitaille JM. Severe retinopathy of prematurity associated with FZD4 mutations. Ophthalmic Genet 2010; 31:37-43. [PMID: 20141357.
16. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol 2005; 123:991-9. [PMID: 16009843.
17. Kondo H, Hayashi H, Oshima K, Tahira T, Hayashi K. Frizzled 4 gene (FZD4) mutations in patients with familial exudative vitreoretinopathy with variable expressivity. Br J Ophthalmol 2003; 87:1291-5. [PMID: 14507768.
18. Kondo H, Qin M, Kusaka S, Tahira T, Hasebe H, Hayashi H, Uchio E, Hayashi K. Novel mutations in Norrie disease gene in Japanese patients with Norrie disease and familial exudative vitreoretinopathy. Invest Ophthalmol Vis Sci 2007; 48:1276-82. [PMID: 17325173.
19. Kondo H, Kusaka S, Yoshinaga A, Uchio E, Tawara A, Hayashi K, Tahira T. Mutations in the TSPAN12 gene in Japanese patients with familial exudative vitreoretinopathy. Am J Ophthalmol 2011; 151:1095-100. [PMID: 21334594.
20. Gordon D, Abajian C, Green P. Consed: a graphical tool for sequence finishing. Genome Res 1998; 8:195-202. [PMID: 9521923.
21. Qin M, Hayashi H, Oshima K, Tahira T, Hayashi K, Kondo H. Complexity of the genotype-phenotype correlation in familial exudative vitreoretinopathy with mutations in the LRP5 and/or FZD4 genes. Hum Mutat 2005; 26:104-12. [PMID: 15981244.
22. Thompson JD, Higgins DG, Gibson TJ. CLUSTALW: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994; 22:4673-80. [PMID: 7984417.
23. Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 2009; 4:1073-81. [PMID: 19561590.
24. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR. A method and server for predicting damaging missense mutations. Nat Methods 2010; 7:248-9. [PMID: 20354512.
25. Schwarz JM, Rodelsperger C, Schuelke M, Seelow D. MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods 2010; 7:575-6. [PMID: 20676075.
26. Pollard KS, Hubisz MJ, Rosenbloom KR, Siepel A. Detection of nonneutral substitution rates on mammalian phylogenies. Genome Res 2010; 20:110-21. [PMID: 19858363.
27. Liu X, Jian X, Boerwinkle E. dbNSFP: a lightweight database of human nonsynonymous SNPs and their functional predictions. Hum Mutat 2011; 32:894-9. [PMID: 21520341.
28. Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 2010; 38:e164 [PMID: 20601685.
29. Jia LY, Li XX, Yu WZ, Zeng WT, Liang C. Novel frizzled-4 gene mutations in chinese patients with familial exudative vitreoretinopathy. Arch Ophthalmol 2010; 128:1341-9. [PMID: 20938005.
30. Omoto S, Hayashi T, Kitahara K, Takeuchi T, Ueoka Y. Autosomal dominant familial exudative vitreoretinopathy in two Japanese families with FZD4 mutations (H69Y and C181R). Ophthalmic Genet 2004; 25:81-90. [PMID: 15370539.
31. Chung BD, Kayserili H, Ai M, Freudenberg J, Uzumcu A, Uyguner O, Bartels CF, Honing S, Ramirez A, Hanisch FG, Nurnberg G, Nurnberg P, Warman ML, Wollnik B, Kubisch C, Netzer C. A mutation in the signal sequence of LRP5 in a family with an osteoporosis-pseudoglioma syndrome (OPPG)-like phenotype indicates a novel disease mechanism for trinucleotide repeats. Hum Mutat 2009; 30:641-8. [PMID: 19177549.
32. Strachan T, Read A. Mapping genes conferring susceptibility of complex diseases. Human molecular genetics. 4th ed. New York: Garland Science; 2011. p. 467-96.
33. Perrault I, Hanein S, Zanlonghi X, Serre V, Nicouleau M, Defoort-Delhemmes S, Delphin N, Fares-Taie L, Gerber S, Xerri O, Edelson C, Goldenberg A, Duncombe A, Le Meur G, Hamel C, Silva E, Nitschke P, Calvas P, Munnich A, Roche O, Dollfus H, Kaplan J, Rozet JM. Mutations in NMNAT1 cause Leber congenital amaurosis with early-onset severe macular and optic atrophy. Nat Genet 2012; 44:975-7. [PMID: 22842229.
34. Wu WC, Drenser K, Trese M, Capone A Jr, Dailey W. Retinal phenotype-genotype correlation of pediatric patients expressing mutations in the Norrie disease gene. Arch Ophthalmol 2007; 125:225-30. [PMID: 17296899.
35. Kenyon JR, Craig IW. Analysis of the 5′ regulatory region of the human Norrie's disease gene: evidence that a nontranslated CT dinucleotide repeat in exon one has a role in controlling expression. Gene 1999; 227:181-8. [PMID: 10023053.
36. MacDonald ML, Goldberg YP, Macfarlane J, Samuels ME, Trese MT, Shastry BS. Genetic variants of frizzled-4 gene in familial exudative vitreoretinopathy and advanced retinopathy of prematurity. Clin Genet 2005; 67:363-6. [PMID: 15733276.
37. Drenser KA, Dailey W, Vinekar A, Dalal K, Capone A Jr, Trese MT. Clinical presentation and genetic correlation of patients with mutations affecting the FZD4 gene. Arch Ophthalmol 2009; 127:1649-54. [PMID: 20008721.
38. Nallathambi J, Shukla D, Rajendran A, Namperumalsamy P, Muthulakshmi R, Sundaresan P. Identification of novel FZD4 mutations in Indian patients with familial exudative vitreoretinopathy. Mol Vis 2006; 12:1086-92. [PMID: 17093393.
39. Qin M, Kondo H, Tahira T, Hayashi K. Moderate reduction of Norrin signaling activity associated with the causative missense mutations identified in patients with familial exudative vitreoretinopathy. Hum Genet 2008; 122:615-23. [PMID: 17955262.
40. Nikopoulos K, Venselaar H, Collin RW, Riveiro-Alvarez R, Boonstra FN, Hooymans JM, Mukhopadhyay A, Shears D, van Bers M, de Wijs IJ, van Essen AJ, Sijmons RH, Tilanus MA, van Nouhuys CE, Ayuso C, Hoefsloot LH, Cremers FP. Overview of the mutation spectrum in familial exudative vitreoretinopathy and Norrie disease with identification of 21 novel variants in FZD4, LRP5, and NDP. Hum Mutat 2010; 31:656-66. [PMID: 20340138.